Upgrade to SI Premium - Free Trial

JPMorgan Reinstates Emergent BioSolutions (EBS) at Underweight

August 21, 2026 3:28 AM
JPMorgan analyst Jessica Fye reinstates coverage on Emergent BioSolutions ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage